Irreversible inhibitors useful for the treatment of kinase-related pathologies

Details for Australian Patent Application No. 2010299835 (hide)

Owner Centre National De La Recherche Scientifique Universite de Strasbourg

Inventors Winssinger, Nicolas; Barluenga, Sofia

Agent Davies Collison Cave

Pub. Number AU-A-2010299835

PCT Pub. Number WO2011/036299

Priority 61/306,669 22.02.10 US; 61/246,361 28.09.09 US

Filing date 28 September 2010

Wipo publication date 31 March 2011

International Classifications

C07D 313/00 (2006.01) Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom

A61K 31/335 (2006.01) - having oxygen as the only ring hetero atom, e.g. fungichromin

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

5 April 2012 PCT application entered the National Phase

  PCT publication WO2011/036299 Priority application(s): WO2011/036299

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010299850-Electrode for electrolytic processes with controlled crystalline structure

2010299820-Benzoxepin PI3K inhibitor compounds and methods of use